Sunrun Sinks 39% on House Passage of Energy Tax Rollback
Sunrun Inc. (RUN) plunged 39.35% to lead losses in the PRISM Emerging New Energy Index after the House passed a tax-and-spending package that deals a major blow to clean energy incentives. The bill aims to roll back key provisions of the Inflation Reduction Act (IRA), including federal tax credits for both utility-scale and residential solar. Crucially, the approved version removes credits not only for homeowner-owned systems but also for leased systems, an area that supports roughly 70% of the U.S. residential solar market.
Biodexa Pharmaceuticals Gains 24% on Phase 3 Trial Funding
Biodexa Pharmaceuticals PLC (BDRX) rose 23.83%, bolstering the PRISM Emerging Pharmaceuticals Index, after announcing an additional $3.0 million grant from the Cancer Prevention & Research Institute of Texas (CPRIT). The funds support the company’s registrational Phase 3 program of eRapa, an investigational treatment for familial adenomatous polyposis (FAP), a rare inherited disorder that often leads to colorectal cancer. The new award brings total CPRIT funding for the trial to $20 million. Patient recruitment is expected to begin in the coming weeks across sites in the U.S. and Europe.
Other PRISM Mid-Day Movers:
- Catheter Precision, Inc. (VTAK): -28.61%
- IonQ, Inc. (IONQ): +27.37%
- Village Farms International, Inc. (VFF): +15.09%
- Creative Realities, Inc. (CREX): +13.37%
The post PRISM Mid-Day Movers: Clean Energy Incentive Rollbacks Sink Solar Stocks, Biopharma Gains Ground appeared first on PRISM MarketView.
